Drugs / Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution
Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00651612 | Nov 2005 → Jan 2007 | glaucoma, ocular hypertension | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00651612 ↗ |
| Route | Other | “1 drop instilled in each eye two times daily (morning and evening)” NCT00651612 ↗ |